MGC Diagnostics Corporation is a medical technology company, which offers cardiorespiratory health solutions. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. It sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals, university-based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers and clinical research organizations (CROs). Its cardiorespiratory diagnostic products measure flow and respiratory pressures and, in most cases analyze the inhaled and exhaled gases, such as oxygen and carbon dioxide. Its products include pulmonary function (PFT) and gas exchange (GX) testing products. The Company's pulmonary function products are divided into four product categories: Spirometry, Complete Pulmonary Function, Body Plethysmography and Specialty Products.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Advanced Medical Equipment & Technology - NEC
- Sub-Industry: N/A
- Symbol: NASDAQ:ANGN
- CUSIP: N/A
- Web: mgcdiagnostics.com
- Trailing P/E Ratio:
- P/E Growth:
- Net Margins: -0.26%
- Return on Equity: -0.75%
- Return on Assets: -0.37%
Frequently Asked Questions for MGC Diagnostics Corp (NASDAQ:ANGN)
What is MGC Diagnostics Corp's stock symbol?
MGC Diagnostics Corp trades on the NASDAQ under the ticker symbol "ANGN."
Who are some of MGC Diagnostics Corp's key competitors?
Some companies that are related to MGC Diagnostics Corp include Thermo Fisher Scientific (TMO), Danaher Corporation (DHR), Boston Scientific Corporation (BSX), Intuitive Surgical (ISRG), Koninklijke Philips N.V. (PHG), Illumina (ILMN), Edwards Lifesciences Corporation (EW), Cerner Corporation (CERN), Agilent Technologies (A), Waters Corporation (WAT), Hologic (HOLX), ResMed (RMD), Varian Medical Systems (VAR), PerkinElmer (PKI), ABIOMED (ABMD), Bruker Corporation (BRKR), Alere (ALR) and Accelerate Diagnostics (AXDX).
Who are MGC Diagnostics Corp's key executives?
MGC Diagnostics Corp's management team includes the folowing people:
- Mark W. Sheffert, Independent Chairman of the Board
- Matthew S. Margolies, President
- Todd M. Austin, Chief Executive Officer
- Jill D. Burchill, Principal Financial Officer
- Larry R. Degen, Principal Accounting Officer, Secretary
- John R. Baudhuin, Independent Director
- Terrence W. Bunge, Independent Director
- Wendy D. Lynch Ph.D., Independent Director
- Robert E. Munzenrider CPA, Independent Director
- Hendrik Struik, Independent Director
How do I buy MGC Diagnostics Corp stock?
Shares of MGC Diagnostics Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is MGC Diagnostics Corp's stock price today?
MarketBeat Community Rating for MGC Diagnostics Corp (NASDAQ ANGN)MarketBeat's community ratings are surveys of what our community members think about MGC Diagnostics Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of MGC Diagnostics Corp stock can currently be purchased for approximately $5.33.
Consensus Ratings for MGC Diagnostics Corp (NASDAQ:ANGN) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for MGC Diagnostics Corp (NASDAQ:ANGN)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for MGC Diagnostics Corp (NASDAQ:ANGN)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for MGC Diagnostics Corp (NASDAQ:ANGN)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History by Quarter for MGC Diagnostics Corp (NASDAQ ANGN)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading History for MGC Diagnostics Corp (NASDAQ:ANGN)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for MGC Diagnostics Corp (NASDAQ:ANGN)
Latest Headlines for MGC Diagnostics Corp (NASDAQ:ANGN)
No headlines for this company have been tracked by MarketBeat.com
MGC Diagnostics Corp (ANGN) Chart for Friday, July, 21, 2017